Allenbach, Y., Benveniste, O. :
Apport des auto-anticorps au cours des myopathies auto-immunes.
Rev Neurol (Paris), 2013 ; (SP) :
Publications (1181)
Cattin, M. E., Bertrand, A. T., Schlossarek, S., Le Bihan, M. C., Jensen, S. S., Neuber, C., Crocini, C., Maron, S., Laine, J., Mougenot, N., Varnous, S., Fromes, Y., Hansen, A., Eschenhagen, T., Decostre, V., Carrier, L., Bonne, G. :
Heterozygous LmnadelK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency and peptide toxicity Hum Mol Genet, 2013 ; 22 (15) : 3152-64
Heterozygous LmnadelK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency and peptide toxicity Hum Mol Genet, 2013 ; 22 (15) : 3152-64
Carlier, R Y, Carlier, P :
Intérêt de l’IRM musculaire dans l’enquête étiologique des dystrophies musculaires (dystrophie « des ceintures ») La Lettre du Neurologue, 2013 ; 17 (1) : 24-25
Intérêt de l’IRM musculaire dans l’enquête étiologique des dystrophies musculaires (dystrophie « des ceintures ») La Lettre du Neurologue, 2013 ; 17 (1) : 24-25
Polesskaya, A., Degerny, C., Pinna, G., Maury, Y., Kratassiouk, G., Mouly, V., Morozova, N., Kropp, J., Frandsen, N., Harel-Bellan, A. :
Genome-Wide Exploration of miRNA Function in Mammalian Muscle Cell Differentiation PLoS ONE, 2013 ; 8 (8) : e71927
Genome-Wide Exploration of miRNA Function in Mammalian Muscle Cell Differentiation PLoS ONE, 2013 ; 8 (8) : e71927
Hervier, B., Benveniste, O. :
Clinical heterogeneity and outcomes of antisynthetase syndrome Curr Rheumatol Rep, 2013 ; 15 (8) : 349
Clinical heterogeneity and outcomes of antisynthetase syndrome Curr Rheumatol Rep, 2013 ; 15 (8) : 349
McPhee, J. S., Hogrel, J. Y., Maier, A. B., Seppet, E., Seynnes, O. R., Sipila, S., Bottinelli, R., Barnouin, Y., Bijlsma, A. Y., Gapeyeva, H., Maden-Wilkinson, T. M., Meskers, C. G., Paasuke, M., Sillanpaa, E., Stenroth, L., Butler-Browne, G., Narici, M. V., Jones, D. A. :
Physiological and functional evaluation of healthy young and older men and women: design of the European MyoAge study Biogerontology, 2013 ; 4 (3) : 325-337
Physiological and functional evaluation of healthy young and older men and women: design of the European MyoAge study Biogerontology, 2013 ; 4 (3) : 325-337
Kuster, D. W., Sequeira, V., Najafi, A., Boontje, N., J. M. Wijnker P, Witjas-Paalberends, R., Marston, S., Dos Remedios, C. G., Carrier, L., Demmers, J. A., Redwood, C. S., Sadayappan, S., van der Velden, J. :
GSK3beta Phosphorylates Newly Identified Site in the Pro-Ala Rich Region of Cardiac Myosin Binding Protein C and Alters Cross-Bridge Cycling Kinetics in Human Circ Res, 2013 ; 112 (4) : 633-639
GSK3beta Phosphorylates Newly Identified Site in the Pro-Ala Rich Region of Cardiac Myosin Binding Protein C and Alters Cross-Bridge Cycling Kinetics in Human Circ Res, 2013 ; 112 (4) : 633-639
Bonne, G., Quijano-Roy, S. :
Emery-Dreifuss muscular dystrophy, laminopathies, and other nuclear envelopathies Handb Clin Neurol, 2013 ; 113 : 1367-76
Emery-Dreifuss muscular dystrophy, laminopathies, and other nuclear envelopathies Handb Clin Neurol, 2013 ; 113 : 1367-76
Simon, D., Alberti, C., Alison, M., Le Henaff, L., Chevenne, D., Boizeau, P., Canal, A., Ollivier, G., Decostre, V., Jacqz-Aigrain, E., Carel, J. C., Czernichow, P., Hogrel, J. Y. :
Effects of recombinant human growth hormone for 1 year on body composition and muscle strength in children on long-term steroid therapy: randomized controlled, delayed-start study J Clin Endocrinol Metab, 2013 ; 98 (7) : 2746-54
Effects of recombinant human growth hormone for 1 year on body composition and muscle strength in children on long-term steroid therapy: randomized controlled, delayed-start study J Clin Endocrinol Metab, 2013 ; 98 (7) : 2746-54
Rendu, J, Brocard, J, Denarier, E, Monnier, N, Piétri-Rouxel, F, Beley, C, Roux-Buisson, N, Gilbert-Dussardier, B, Perez, M J, Romero, N, Garcia, L, Lunardi, J, Fauré, J, Fourest-Lieuvin, A, Marty, I. :
Exon skipping as a therapeutic strategy applied to a RyR1 mutation with pseudo-exon inclusion causing a severe core myopathy Hum Gene Ther, 2013 ; 24 (7) : 702-13
Exon skipping as a therapeutic strategy applied to a RyR1 mutation with pseudo-exon inclusion causing a severe core myopathy Hum Gene Ther, 2013 ; 24 (7) : 702-13
